Sensus Healthcare, Inc. (SRTS)
USD 4.9
(-2.58%)
USD 4.9
(-2.58%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.44 Million USD | -2.4% |
| 2022 | 14.79 Million USD | 14.99% |
| 2021 | 12.86 Million USD | -4.56% |
| 2020 | 13.48 Million USD | -30.95% |
| 2019 | 19.52 Million USD | 3.22% |
| 2018 | 18.91 Million USD | 7.99% |
| 2017 | 17.51 Million USD | 71.59% |
| 2016 | 10.2 Million USD | 50.23% |
| 2015 | 6.79 Million USD | -8.61% |
| 2014 | 7.43 Million USD | 10.13% |
| 2013 | 6.75 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.44 Million USD | -8.85% |
| 2024 Q1 | 3.77 Million USD | 67.63% |
| 2023 Q4 | 2.25 Million USD | -42.02% |
| 2023 Q1 | 4.56 Million USD | 9.17% |
| 2023 Q2 | 3.74 Million USD | -17.87% |
| 2023 Q3 | 3.88 Million USD | 3.68% |
| 2023 FY | 14.44 Million USD | -2.4% |
| 2022 Q3 | 3.71 Million USD | 0.73% |
| 2022 Q4 | 4.17 Million USD | 12.52% |
| 2022 FY | 14.79 Million USD | 14.99% |
| 2022 Q1 | 3.21 Million USD | -8.96% |
| 2022 Q2 | 3.68 Million USD | 14.51% |
| 2021 Q4 | 3.53 Million USD | 17.63% |
| 2021 Q3 | 3 Million USD | -17.05% |
| 2021 Q2 | 3.62 Million USD | 34.17% |
| 2021 FY | 12.86 Million USD | -4.56% |
| 2021 Q1 | 2.7 Million USD | -9.09% |
| 2020 Q2 | 3.21 Million USD | -26.04% |
| 2020 FY | 13.48 Million USD | -30.95% |
| 2020 Q4 | 2.97 Million USD | 0.66% |
| 2020 Q3 | 2.95 Million USD | -8.17% |
| 2020 Q1 | 4.34 Million USD | -2.86% |
| 2019 Q4 | 4.47 Million USD | -3.77% |
| 2019 FY | 19.52 Million USD | 3.22% |
| 2019 Q2 | 4.89 Million USD | -11.17% |
| 2019 Q3 | 4.64 Million USD | -5.0% |
| 2019 Q1 | 5.5 Million USD | 14.06% |
| 2018 Q4 | 4.83 Million USD | 5.18% |
| 2018 FY | 18.91 Million USD | 7.99% |
| 2018 Q1 | 5.05 Million USD | 7.26% |
| 2018 Q2 | 4.43 Million USD | -12.18% |
| 2018 Q3 | 4.59 Million USD | 3.44% |
| 2017 Q3 | 4.18 Million USD | 0.08% |
| 2017 Q2 | 4.18 Million USD | -5.92% |
| 2017 Q1 | 4.44 Million USD | 33.76% |
| 2017 Q4 | 4.71 Million USD | 12.65% |
| 2017 FY | 17.51 Million USD | 71.59% |
| 2016 Q1 | 1.92 Million USD | -3.05% |
| 2016 Q2 | 2.66 Million USD | 38.77% |
| 2016 Q3 | 2.29 Million USD | -14.0% |
| 2016 FY | 10.2 Million USD | 50.23% |
| 2016 Q4 | 3.32 Million USD | 44.71% |
| 2015 Q3 | 1.49 Million USD | -8.86% |
| 2015 Q1 | 1.68 Million USD | 0.0% |
| 2015 FY | 6.79 Million USD | -8.61% |
| 2015 Q4 | 1.98 Million USD | 33.1% |
| 2015 Q2 | 1.63 Million USD | -2.99% |
| 2014 FY | 7.43 Million USD | 10.13% |
| 2013 FY | 6.75 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -28.671% |
| Cerus Corporation | 143.15 Million USD | 89.912% |
| OrthoPediatrics Corp. | 137.01 Million USD | 89.46% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -27.121% |
| Talis Biomedical Corporation | 67.18 Million USD | 78.504% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 42.107% |
| Inogen, Inc. | 236.08 Million USD | 93.883% |
| Spectral AI, Inc. | 20.86 Million USD | 30.78% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 74.209% |
| CVRx, Inc. | 76.14 Million USD | 81.033% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -309.354% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -15.638% |
| Orthofix Medical Inc. | 667.42 Million USD | 97.836% |
| Venus Concept Inc. | 80.47 Million USD | 82.054% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 74.474% |
| Bioventus Inc. | 409.91 Million USD | 96.477% |
| BrainsWay Ltd. | 28.01 Million USD | 48.455% |
| Envoy Medical, Inc. | 17.89 Million USD | 19.309% |
| electroCore, Inc. | 32.03 Million USD | 54.912% |
| IceCure Medical Ltd | 16.87 Million USD | 14.423% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 65.964% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 18.097% |
| MaxCyte, Inc. | 84.84 Million USD | 82.978% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -16.357% |
| Nexalin Technology, Inc. | 5.78 Million USD | -149.803% |
| PAVmed Inc | 64.82 Million USD | 77.722% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 71.726% |
| RxSight, Inc. | 103.85 Million USD | 86.093% |
| Sight Sciences, Inc. | 126.44 Million USD | 88.579% |
| SI-BONE, Inc. | 156.35 Million USD | 90.763% |
| TELA Bio, Inc. | 84.18 Million USD | 82.845% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 79.385% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 92.898% |
| LivaNova PLC | 843.54 Million USD | 98.288% |
| 908 Devices Inc. | 68.08 Million USD | 78.787% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.014% |
| Nemaura Medical Inc. | 7.13 Million USD | -102.303% |
| NeuroPace, Inc. | 75.29 Million USD | 80.82% |
| LENSAR, Inc. | 33.33 Million USD | 56.677% |
| Apyx Medical Corporation | 51.01 Million USD | 71.692% |
| Cutera, Inc. | 197.72 Million USD | 92.696% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 41.721% |
| BioSig Technologies, Inc. | 28.53 Million USD | 49.38% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 92.458% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 59.95% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.273% |
| Axonics, Inc. | 270.2 Million USD | 94.655% |
| Outset Medical, Inc. | 198.77 Million USD | 92.734% |
| IRIDEX Corporation | 31.81 Million USD | 54.605% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 91.986% |
| IRadimed Corporation | 30.12 Million USD | 52.056% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -69.269% |
| INVO Bioscience, Inc. | 7.85 Million USD | -83.897% |
| Telesis Bio, Inc. | 63.48 Million USD | 77.253% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 85.331% |
| Varex Imaging Corporation | 224.8 Million USD | 93.576% |
| Quipt Home Medical Corp. | 148.66 Million USD | 90.286% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -23.194% |
| Pulmonx Corporation | 112.68 Million USD | 87.184% |
| Dynatronics Corporation | 9.9 Million USD | -45.761% |
| Modular Medical, Inc. | 17.52 Million USD | 17.611% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 28.459% |
| Semler Scientific, Inc. | 38.94 Million USD | 62.916% |
| InMode Ltd. | 215.68 Million USD | 93.304% |
| Bruker Corporation | 1.07 Billion USD | 98.658% |
| Cytosorbents Corporation | 48.33 Million USD | 70.122% |
| DexCom, Inc. | 1.69 Billion USD | 99.146% |
| Align Technology, Inc. | 2.07 Billion USD | 99.305% |
| Viveve Medical, Inc. | 22.17 Million USD | 34.867% |
| ZimVie Inc. | 275.12 Million USD | 94.751% |
| Movano Inc. | 29.69 Million USD | 51.357% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 89.479% |
| Nexalin Technology, Inc. | 5.78 Million USD | -149.803% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -309.354% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.597% |
| Profound Medical Corp. | 33.6 Million USD | 57.022% |
| Insulet Corporation | 939.9 Million USD | 98.463% |
| enVVeno Medical Corporation | 25.23 Million USD | 42.777% |
| Surmodics, Inc. | 98.69 Million USD | 85.367% |
| iCAD, Inc. | 22.22 Million USD | 35.019% |
| Nuwellis, Inc. | 22.61 Million USD | 36.134% |
| Biotricity, Inc. | 17.18 Million USD | 15.959% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 96.761% |
| Aethlon Medical, Inc. | 12.27 Million USD | -17.63% |
| InspireMD, Inc. | 22.95 Million USD | 37.072% |
| PAVmed Inc. | 64.82 Million USD | 77.722% |
| BIOLASE, Inc. | 34.66 Million USD | 58.334% |
| Beyond Air, Inc. | 61.7 Million USD | 76.593% |
| FONAR Corporation | 28.6 Million USD | 49.512% |
| AxoGen, Inc. | 149.33 Million USD | 90.329% |
| Vivani Medical, Inc. | 26.96 Million USD | 46.442% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 91.845% |
| Inari Medical, Inc. | 448.59 Million USD | 96.781% |
| UFP Technologies, Inc. | 58.08 Million USD | 75.138% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -193.084% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -128.575% |
| Tenon Medical, Inc. | 16.96 Million USD | 14.887% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -95.347% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 67.254% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.66% |
| Sintx Technologies, Inc. | 15.2 Million USD | 4.993% |
| NanoVibronix, Inc. | 4.97 Million USD | -190.408% |
| Quanterix Corporation | 118.1 Million USD | 87.771% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -23.194% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 96.322% |
| TransMedics Group, Inc. | 182.82 Million USD | 92.1% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 48.541% |
| NeuroMetrix, Inc. | 11.09 Million USD | -30.121% |
| Hyperfine, Inc. | 52.87 Million USD | 72.685% |
| Establishment Labs Holdings Inc. | 172 Million USD | 91.604% |
| Biomerica, Inc. | 6.97 Million USD | -106.965% |
| Bone Biologics Corporation | 9.42 Million USD | -53.177% |
| AVITA Medical, Inc. | 80.77 Million USD | 82.122% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -40.061% |
| Silk Road Medical, Inc | 186.35 Million USD | 92.25% |